Dapagliflozin versus empagliflozin in patients with chronic kidney disease

• Główni autorzy: Hilmi Alnsasra (Autor), Gal Tsaban (Autor), Adam Solomon (Autor), Fouad Khalil (Autor), Enis Aboalhasan (Autor), Abed N. Azab (Autor), Joseph Azuri (Autor), Ariel Hammerman (Autor), Ronen Arbel (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2023-08-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Background and Aim: Dapagliflozin and empagliflozin have demonstrated favorable clinical outcomes among patients with chronic kidney disease (CKD). However, their comparative monetary value for improving outcomes in CKD patients is unestablished. We examined the cost-per-outcome implications of util...